Clearance dysfunction of trans-barrier transport and lymphatic drainage in cerebral small vessel disease: Review and prospect

Neurobiol Dis. 2023 Dec:189:106347. doi: 10.1016/j.nbd.2023.106347. Epub 2023 Nov 10.

Abstract

Cerebral small vessel disease (CSVD) causes 20%-25% of stroke and contributes to 45% of dementia cases worldwide. However, since its early symptoms are inconclusive in addition to the complexity of the pathological basis, there is a rather limited effective therapies and interventions. Recently, accumulating evidence suggested that various brain-waste-clearance dysfunctions are closely related to the pathogenesis and prognosis of CSVD, and after a comprehensive and systematic review we classified them into two broad categories: trans-barrier transport and lymphatic drainage. The former includes blood brain barrier and blood-cerebrospinal fluid barrier, and the latter, glymphatic-meningeal lymphatic system and intramural periarterial drainage pathway. We summarized the concepts and potential mechanisms of these clearance systems, proposing a relatively complete framework for elucidating their interactions with CSVD. In addition, we also discussed recent advances in therapeutic strategies targeting clearance dysfunction, which may be an important area for future CSVD research.

Keywords: Blood-brain barrier; Blood–cerebrospinal fluid barrier; Cerebral small vessel disease; Glymphatic system; Intramural periarterial drainage pathway; Meningeal lymphatic vessels.

Publication types

  • Review

MeSH terms

  • Blood-Brain Barrier / metabolism
  • Brain / metabolism
  • Cerebral Small Vessel Diseases*
  • Glymphatic System*
  • Humans
  • Meninges
  • Stroke*